From: Becker's GI & Endoscopy <editorial@beckershealthcare.com>
Subject: Dr. Peter Pronovost: This unnecessary regulation doesn't benefit patients and costs $500M each year | Mayo Clinic testing colon cancer breathalyzer in clinical trial: 4 insights | 10 key points on malpractice premiums in 2016 | Bowel cancer mortality rates drop 30% - 4 study insights
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ 

                 
 
April 20, 2017 
Today's Top Stories
1. Dr. Peter Pronovost: This unnecessary regulation doesn't benefit patients and costs $500M each year 

2. Mayo Clinic testing colon cancer breathalyzer in clinical trial: 4 insights Full story
3. GI leader to know: Dr. Louis Leite of Pennsylvania Gastroenterology  Full story

4. Whitepaper: Learn strategies to improve ASC financial performance, including improved billing, collections and payor rates in this upcoming webinar.  Download today!

5. 10 key points on malpractice premiums in 2016  Full story

6. Bowel cancer morality rates drop 30%: 4 notes  Full story 

7. Massachusetts takes on price transparency through one-stop shop website Full story
   
8. Canada's high childhood IBD rate continues to rise: 5 key notes Full story

9. CMS wants to make accrediting organization surveys public  Full story

10. 2 new GI-driven ASCs & facilities Full story 
 
11. Andrews Institute celebrates 10-year anniversary - 5 takeaways  Full story 
                
                                                        
               
                
              
Channels
_____________________
Contact Us

Editorial Contact: 
Laura Dyrda   
Editor in Chief  
(312) 253-9170
email Laura

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's ASC Review
A Becker's Healthcare Publication
17 N. State, Suite 1800| Chicago, IL 60602




Copyright © 2016. All Rights Reserved.